| Followers | 22 |
| Posts | 2352 |
| Boards Moderated | 1 |
| Alias Born | 09/27/2020 |
Thursday, October 03, 2024 6:41:26 AM
Form 8-K
Novavax, Inc. (“Novavax”) is aware of an analyst report published on October 1, 2024, which referred to discussions with Novavax’s management regarding, among other things, the anticipated U.S. market for COVID-19 vaccination for the 2024-2025 vaccination season. Novavax would like to clarify that while it has anticipated the COVID-19 vaccination market in the U.S. will be similar to last year, it has neither updated nor reaffirmed its full year 2024 financial guidance issued on August 8, 2024.
Recent NVAX News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/12/2025 09:17:57 PM
- Novavax to Participate in Jefferies London Healthcare Conference • PR Newswire (US) • 11/12/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 01:00:22 PM
- Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights • PR Newswire (US) • 11/06/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 12:47:47 PM
- Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment • PR Newswire (US) • 11/04/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 11:02:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 08:30:19 PM
- Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 • PR Newswire (US) • 10/30/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 11:00:50 AM
- Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy • PR Newswire (US) • 10/22/2025 11:00:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/14/2025 11:45:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 11:00:33 AM
- Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment • PR Newswire (US) • 10/07/2025 11:00:00 AM
- Novavax Announces Progress on Sanofi Agreement • PR Newswire (US) • 09/30/2025 01:01:00 PM
- Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment • PR Newswire (US) • 09/04/2025 12:00:00 PM
- Novavax to Participate in the Cantor Global Healthcare Conference • PR Newswire (US) • 09/03/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:40:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2025 08:38:26 PM
- Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. • PR Newswire (US) • 08/27/2025 07:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2025 11:48:52 AM
- Novavax Announces Convertible Debt Refinancing • PR Newswire (US) • 08/21/2025 11:43:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 12:04:19 PM
- Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights • PR Newswire (US) • 08/06/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 11:47:13 AM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • IONI • Dec 4, 2025 8:30 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now • PFE • Dec 2, 2025 9:00 AM
Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order • BLO • Dec 2, 2025 8:50 AM
